Data protection Impressum

Newsroom

BioLizard’s move to Lausanne reflects its growing international presence and dedication to serving the Swiss biotech industry.

Bioinformatics specialist BioLizard opens a new office at the Biopôle in Lausanne

24 January 2024

This achievement, part of the PILATUS First-In-Human Clinical study (ClinicalTrials ID: NCT06119607), marks a new era in the field of valve replacement.

Novostia successfully implants its TRIFLO Heart Valve Implant in first human patient

24 January 2024

Timeline’s new funding round, led by BOLD (Business Opportunities for L’Oréal Development), includes strategic investments from industry giants L’Oréal and Nestlé.

Timeline secures CHF 56 million to propel its pioneering role in longevity and healthy aging

24 January 2024

Nicolas Collin, Co-Founder and CEO of the Vaccine Formulation Institute (VFI), discusses the innovative approach and global impact of their work in developing high-quality, accessible adjuvants for vaccines and why Geneva was chosen as the ideal location for VFI's impactful work.

Why the Vaccine Formulation Institute chose Western Switzerland

23 January 2024

Cellestia Biotech is pioneering innovative therapeutics based on novel modes of action to treat autoimmune diseases and multi-drug resistant cancers.

Cellestia Biotech receives CHF 2 million for its pioneering GvHD prevention therapy

23 January 2024

Representatives from CSEM, UNIGE, and ESO on the balcony of the Neuchâtel. CSEM developed the laser frequency comb that will work together with the NIRPS spectrograph to search for exoplanets.

UNIGE and CSEM collaborate on exoplanet research with cutting-edge technology

23 January 2024

The EUR 1.8 million initiative, funded by the Eurostars program, focuses on developing a secure, privacy-preserving machine learning platform for Electronic Health Records (EHR) in pediatric emergency care.

Tune Insight spearheads Eurostars project for secure AI in pediatric emergency care

22 January 2024

This marks the third consecutive year Bern has held this prestigious position, attributed to its outstanding facilities, minimal air pollution, and low crime rates.

Bern maintains top spot for expat liveability in Europe

22 January 2024

STALICLA has developed the first neurodevelopmental disorder-specific precision medicine platform with an initial application in autism spectrum disorder (ASD).

STALICLA secures USD 17.4 million to propel neuro precision medicine

22 January 2024

Biomass fermentation leverages the rapid growth cycle and high protein content of many fungi to efficiently produce large quantities of protein.

Planetary collaborates with Konica Minolta to enhance microbial fermentation

22 January 2024

1 … 48 49 50 51 52 53 54 55 56 … 149